Targeted transgene expression using the human HLA-DRA promoter in a retroviral vector.
BioTransplant Inc, Boston, Massachusetts, USA.
S
S
Muthukumar
M
M
Denaro
P T
PT
Banerjee
M E
ME
White-Scharf
G
G
Andersson
D000818:Animals; D001402:B-Lymphocytes; D002460:Cell Line; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins; D006684:HLA-DR Antigens / Q000235:genetics* / Q000276:immunology; D059805:HLA-DR alpha-Chains; D004854:Herpesvirus 4, Human; D006801:Humans; D008164:Luminescent Proteins / Q000032:analysis / Q000235:genetics; D051379:Mice; D008979:Moloney murine leukemia virus; D011401:Promoter Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D014162:Transfection; D014407:Tumor Cells, Cultured
D006684:HLA-DR Antigens; D059805:HLA-DR alpha-Chains; D008164:Luminescent Proteins; D011993:Recombinant Fusion Proteins; D049452:Green Fluorescent Proteins